[Federal Register: December 4, 2007 (Volume 72, Number 232)]
[Notices]               
[Page 68193]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04de07-98]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 16, 2007, and published in the Federal 
Register on August 27, 2007 (72 FR 49018), Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers for formulation into finished 
pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemicals, Inc. to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-23480 Filed 12-3-07; 8:45 am]

BILLING CODE 4410-09-P